Client: leading German generic company

The challenge

When our client’s company was acquired by a private equity investor, they urgently needed a strong growth programme – and key executives to support that development.

Our approach

The firm could have hired a senior manager, or appointed the director of a subsidiary to the role, but recognised that they could not match the level of expertise that Pharmawise offered.

Pharmawise provided specialists who hit the ground running, developing strategic options, pipeline and partnerships very quickly. This interim management team, which worked with the firm for 18 months until it was sold, established processes for:

• Undertaking competitor analysis
• Evaluating opportunities for new business
• Formulating new product development strategies and recommendations
• Assessing licensing and production opportunities
• Sourcing and negotiating rights to suitable products.

Result

With our network of experts we were able to deliver the people needed to accelerate the value growth in the business to exit. Their ability to quickly establish and grow a bigger pipeline resulted in a high multiple valuation.
Pharmawise now acts as mentors to board members from outside the pharma industry, a role that helps us to maintain hands-on knowledge.

‍

‍

‍